About us

Valisure is an independent laboratory and partner for quality that provides increased transparency and quality assurance throughout the healthcare industry. In response to rising concerns and quality issues in the global supply chain, Valisure’s team of Harvard- and Yale-trained scientists developed proprietary analytical technologies to independently test products, identify critical issues, and offer services to help distinguish quality stakeholders and products. Valisure’s novel approach to independent quality assurance has had a tremendous global impact and built a foundation of thought leadership that increasingly influences academia, government, and private industry to help improve public health.

2015

Valisure is founded and funded by a team of Yale entrepreneurs.

Valisure was founded and funded by a team of Yale entrepreneurs.

2016

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Tellus sapien sed ullamcorper malesuada nulla a, enim tempus. Eget maecenas tortor elementum non.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Tellus sapien sed ullamcorper malesuada nulla a, enim tempus. Eget maecenas tortor elementum non.

2017

Valisure becomes an ISO 17025 accredited laboratory.

Valisure achieves laboratory accreditation to ISO 17025

2018

Valisure successfully builds and licenses the first online pharmacy that dispenses chemically-validated medications

  • April 2018 - Valisure Wins Pre-Revenue Venture Of The Year In The 2018 Connecticut  Entrepreneur Awards
  • November 2018 - Valisure Publishes Its First Study Titled, “Rapid And Fast-Release Acetaminophen Gelcaps Dissolve Slower Than Acetaminophen Tablets”

2019

Valisure files its first two FDA Citizen Petitions and has a global impact

  • June 2019 -  Valisure Detects DMF Carcinogen In Valsartan (Blood Pressure Drug) And Files Its First Citizen Petition.
  • September 2019 - Valisure Detects NDMA Carcinogen In Ranitidine (Zantac) And Nizatidine (Axid) And Files Its Second Citizen Petition.
  • September 2019 - Wired Magazine Names Valisure As One Of Three Companies Fixing The Drug Industry.
  • November 2019 - U.S. Senator Chris Murphy Honors Valisure With His Office’s Innovator Award.
  • November 2019 - 40+ Countries Act Upon Valisure’s Study Of Ranitidine’s Fundamental Instability.

2020

Valisure’s independent testing and subsequent discoveries generate a growing impact recognized by government and industry

  • January 2020 - Valisure Is Invited To A Joint Press Conference With CongresswomanRosa Delauro Reintroducing A Bill To Give FDA Mandatory Recall Authority Over Drugs.
  • February 2020 - Valisure Speaks At FDA's Duke Margolis ThinkTank On Perceptions On Pharmaceutical Quality.
  • March 2020 - Valisure Detects NDMA Carcinogen In Metformin (Top Diabetes Drug) And Files Its Third Citizen Petition.
  • March 2020 - Valisure Is The First Company To Be Named By MedPage As A Healthcare Disruptor.
  • April 2020 - Valisure Speaks At The Summit On Safe Effective High-Quality Medicines.
  • April 2020 - Valisure Is A Keynote Speaker At The INTERPHEX Pharmaceutical Technology Conference.
  • June 2020 - David Light Testifies Before The US Senate FinanceCommittee On FDA Inspections.
  • September 2020 - Valisure Participates In A Pharmaceutical Shortages &Quality Certification Program.
  • September 2020 - Valisure Invited By JustMedicine To Participate In A Pharmaceutical Shortages & Quality Certification Program.
  • December 2020 - GSK Publishes Root Cause Analysis Paper On Ranitidine, Confirming Valisure’s 2019 Theory Of The Drug Reacting With Itself To Form NDMA.

2021

Valisure’s business evolves from direct-to-consumer into enterprise services as impact grows both in drug and consumer products

  • March 2021 - Valisure Detects Benzene Carcinogen In Hand Sanitizers And Files Its Fourth Citizen Petition.
  • May 2021 - Valisure Sells Its Pharmacy Business To Medly Pharmacy And Announces Partnership To Expand Distribution Of Certified Drugs.
  • May 2021 - Valisure Detects Benzene Carcinogen In Sunscreens And Files Its Fifth Citizen Petition.
  • May 2021 - Valisure And GOJO Industries Inc. (Makers Of Purell) File Joint Letter To Fda Presenting New Research And Requesting Withdrawal Of Emergency Policy.
  • June 2021 - Invited Presenter By Agilent Technologies On Benzene Contamination.
  • September 2021 - Valisure Speaks At CHPA (Consumer Healthcare Products Association) Regulatory Science And Quality Conference.
  • October 2021 - Valisure Speaks At The Industry Studies Association Pharmaceutical Supply Chain Conference.
  • October 2021 - FDA Grants Valisure's And GOJO Industries Inc.'s (Makers Of Purell) Requests And Withdraws Emergency Hand Sanitizer Policy.
  • November 2021 - Valisure Detects Benzene Carcinogen In Body Sprays And Files Its Sixth Citizen Petition.
  • December 2021 - FDA Requests The Industry Starts Testing For Benzene And Identify Potential Sources Of Contamination Previously Suggested By Valisure.

Our History & Timeline

Valisure sees the gap of independent testing as an opportunity, and the journey has been very personal. Founders Adam Clark-Joseph and David Light, friends since their Yale days, reconnected after Adam suffered severe complications from his anticonvulsant medication due to batch variability. Shocked by the vulnerability of the existing drug supply chain, they began to grasp the magnitude and pervasiveness of the problem throughout the pharmaceutical industry. Working together to bring a team of like-minded scientists and pharmacy experts to create Valisure, they founded a company dedicated to bringing improvements in quality and consistency to consumers and the overall healthcare industry. 

Learn More

Valisure successfully builds and licenses the first online pharmacy that dispenses chemically-validated medications

Valisure’s independent testing and subsequent discoveries generate a growing impact recognized by government and industry

Valisure was founded and funded by a team of Yale entrepreneurs.

Valisure achieves laboratory accreditation to ISO 17025

Valisure files its first two FDA Citizen Petitions and has a global impact

Valisure’s business evolves from direct-to-consumer into enterprise services as impact grows both in drug and consumer products

2015

2017

2018

2019

2020

2021

LEADERSHIP TEAM

SIGN UP FOR THE VALISURE NEWSLETTER 

Sign up to stay updated with Valisure announcements, relevant industry news, company updates, and more. 

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.